Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-Aβ antibody
J. Clin. Invest. Kelly R. Bales, et al. 116:825
doi:10.1172/JCI27120 [Go to this article.]

Figure 4
Relative mRNA level of ChT-1 in the hippocampus of young (2 months of age) and old (17 months of age) WT and PDAPP transgenic mice as determined by real-time quantitative PCR amplification. n = 5 mice per group. **P < 0.01, *P < 0.05 versus respective 17-month-old groups.